CAFFARRA, Paolo
 Distribuzione geografica
Continente #
EU - Europa 12.888
NA - Nord America 6.659
AS - Asia 6.014
SA - Sud America 777
AF - Africa 265
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 26.624
Nazione #
IT - Italia 8.877
US - Stati Uniti d'America 6.441
SG - Singapore 2.247
CN - Cina 1.620
VN - Vietnam 781
IE - Irlanda 642
BR - Brasile 591
SE - Svezia 577
DE - Germania 496
FI - Finlandia 481
NL - Olanda 476
HK - Hong Kong 449
UA - Ucraina 349
FR - Francia 317
TR - Turchia 282
ZA - Sudafrica 188
GB - Regno Unito 184
CA - Canada 164
BD - Bangladesh 162
IN - India 125
CH - Svizzera 116
RU - Federazione Russa 79
AT - Austria 70
AR - Argentina 65
JP - Giappone 46
PH - Filippine 42
ES - Italia 40
IQ - Iraq 35
EC - Ecuador 33
BE - Belgio 32
MX - Messico 31
ID - Indonesia 28
PK - Pakistan 27
PL - Polonia 27
RO - Romania 26
TH - Thailandia 25
TW - Taiwan 24
MA - Marocco 18
PY - Paraguay 16
IR - Iran 15
CL - Cile 14
LT - Lituania 14
PE - Perù 14
VE - Venezuela 14
CO - Colombia 13
AU - Australia 12
EG - Egitto 12
PT - Portogallo 11
SA - Arabia Saudita 10
AL - Albania 9
GR - Grecia 9
JO - Giordania 9
KR - Corea 9
MY - Malesia 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
HU - Ungheria 8
KE - Kenya 8
CI - Costa d'Avorio 7
IL - Israele 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
BO - Bolivia 6
DZ - Algeria 6
SM - San Marino 6
BG - Bulgaria 5
EU - Europa 5
RS - Serbia 5
TN - Tunisia 5
BH - Bahrain 4
ET - Etiopia 4
GY - Guiana 4
KW - Kuwait 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
NP - Nepal 4
OM - Oman 4
QA - Qatar 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SI - Slovenia 3
SN - Senegal 3
AO - Angola 2
BW - Botswana 2
HN - Honduras 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
SC - Seychelles 2
SV - El Salvador 2
Totale 26.603
Città #
Singapore 1.055
Milan 948
Rome 677
Chandler 660
Dublin 641
Ashburn 640
San Jose 610
Jacksonville 576
Santa Clara 505
Beijing 494
Hong Kong 419
Ho Chi Minh City 283
Naples 240
Izmir 236
Dearborn 220
Dallas 202
Boardman 201
Nanjing 194
Bologna 184
Turin 176
Johannesburg 175
Hanoi 174
Verona 172
Princeton 152
San Mateo 149
Ann Arbor 143
Parma 143
Padova 141
Florence 137
Lauterbourg 137
New York 123
Genoa 115
Los Angeles 110
Bari 103
Wilmington 96
Catania 93
Palermo 92
Toronto 86
Shanghai 74
Cagliari 72
Nanchang 72
Helsinki 69
São Paulo 65
Vienna 64
Woodbridge 63
Des Moines 61
Hebei 60
Trieste 59
Shenyang 53
Trento 51
Brescia 50
Council Bluffs 49
Moscow 49
Munich 46
Kunming 45
Jinan 43
Venice 43
Columbus 42
Modena 42
Padua 42
Bremen 39
Monza 39
Pescara 39
Ancona 37
Tianjin 37
Buffalo 35
Hefei 33
Perugia 33
Da Nang 32
Pavia 31
Changsha 30
Frankfurt am Main 30
Jiaxing 30
Taranto 29
Haiphong 28
Ottawa 27
Vicenza 27
Mumbai 26
Brussels 25
Guangzhou 25
Udine 25
Torino 24
Houston 23
Genova 22
Messina 22
Pisa 22
Busto Arsizio 21
Hangzhou 21
Napoli 21
Phoenix 21
Rio de Janeiro 21
Salerno 21
Tokyo 21
Amsterdam 20
Treviso 20
Brooklyn 19
Carpi 19
Latina 19
San Genesio Ed Uniti 19
Zurich 19
Totale 13.768
Nome #
Una versione abbreviata del test di Stroop: dati normativi nella popolazione italiana. 7.040
A short version of the Stroop test: Normative data in an Italian population sample 2.078
Italian norms for the Freedman version of the Clock Drawing Test. 1.015
Modified Card Sorting Test: normative data 314
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 215
Visuo-spatial imagery impairment in posterior cortical atrophy: a cognitive and SPECT study. 178
The hormonal pathway to cognitive impairment in older men. 173
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 169
Brain structural substrates of semantic memory decline in Mild Cognitive Impairment. 168
ACTH/Cortisol involvement in the serotonergic disorder affecting the parkinsonian brain. 165
The qualitative scoring MMSE pentagon test (QSPT): A new method for differentiating dementia with Lewy Body from Alzheimer's disease. 163
Functional Disability in Early Alzheimer’s Disease – A Validation Study of the Italian Version of the Disability Assessment for Dementia Scale 161
"Benign recurrent vertigo" and its connection with migraine. 159
Abnormal serotoninergic control of prolactin and cortisol secretion in patients with seasonal affective disorder 158
The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up 158
A case of reversible anti-NMDA-receptor encephalitis: neuropsychological and neuroradiological features 156
Behavioural and cognitive impairment in Parkinson-Dementia and Alzheimer type Dementia., 7, 116,1993. 155
Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorders. 153
Effects of dog-assisted therapies on cognitive mnemonic capabilities in people affected by Alzheimer's disease 152
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 150
ApoE genotype and cognitive functions in Alzheimer’s disease. Alzheimer’s Research 149
Benign recurrent vertigo and its connection with migraine 149
A 6-month, double blind placebo-controlled trial of Eptastigmine in Alzheimer’s disease. Dement Geriatr Cogn Disord 2000;11:17-24 148
Influence of APOE status on lexical-semantic skills in Mild Cognitive Impairment 147
Degenerative jargon aphasia: unusual progression of logopenic/phonological progressive aphasia? 147
A normative study of a shorter version of the Raven Progressive Matrices 1938. 146
[A case of multiple cerebrovascular and migraine episodes caused by the use of oral contraceptives]. 143
Normalità e patologia delle funzioni cognitive nell’invecchiamento. 141
A multicenter Italian randomised study on early treatment of Parkinson disease:comparison of l-dopa, l-deprenyl and dopaminoagonists. Study design and short term results. 140
Efficacia di un programma di stimolazione cognitiva sulle funzioni cognitive e sul metabolismo cerebrale in pazienti con malattia di Alzheimer: dati preliminari di uno studio in aperto 139
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 139
Shortened stroop color-word test: its application in normal aging and Alzheimer's disease. Neurobiol.Aging 1992;13;1;3-4 136
Clinical and Cognitive Phenotype of Mild Cognitive Impairment Evolving to Dementia with Lewy Bodies 135
Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders. A multicenter Italian clinical cross-sectional study on 431 patients. 134
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial 131
Age at onset and SPECT imaging in Alzheimer's disease. 131
[Complicated migraine]. 130
Rey-Osterreith Complex Figure: Normative values in an Italian population sample. 129
Neurofunctional correlates of changes of semantic abilities in Mild Cognitive Impairment (MCI): preliminary results. 128
Explorative study on the cognitive and functional predictors of slow versus rapid disease progression in Alzhiemr's Disease. 127
Semantic Memory Impairment and Neurofunctional Alterations in Mild Cognitive Impairment 125
A Validation study of the Italian version of the disability assessment for dementia in patients with Alzheimer’s disease. 124
Cognitive demand and reminders effect on prospective memory in MCI patients. 120
[Transitory topographical amnesia]. 120
Increased Functional Connectivity in the Default Mode Network in Mild Cognitive Impairment: A Maladaptive Compensatory Mechanism Associated with Poor Semantic Memory Performance 120
Clinical salience of visuospatial memory and structural brain deficits in Mild Cognitive Impairment 117
Diagnostic flow chart for the atypical variants of dementia 117
Utilità e limiti della tomografia ad emissione di fotoni (SPECT) nella Malattia di Alzheimer. 116
MRI multimodal investigation on a small cohort of patients affected by amnestic Mild Cognitive Impairment. 116
L’attivazione cognitiva del paziente demente. In La riabilitazione neuropsicologica. Masson, Milano 1999; 385-394. 115
Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment 114
Transient topographical amnesia. 114
Cognitive demand and reminders effect on time-based prospective memory in amnesic Mild Cognitive Impairment (aMCI) and in healthy elderly 114
Brief practical clinical diagnostic criteria for the neurodegenerative diseases in the elderly 114
Lack of seasonal variation in abnormal TSH secretion in patients with seasonal affective disorder. Biol.Psychiatry;35:36-41;1994 114
L’utilizzo delle reti neurali nella diagnosi differenziale neuropsicologica fra la Demenza a Corpi di Lewy e la Malattia di Alzheimer. 113
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer’s disease. 112
Semiquantitive assessment of regional cerebral perfusion using 99mTc HM-PAO and emission tomography. 112
Failure of oxytocin to affect motor performance in Parkinson's disease. J.Neurol.1985;(suppl.232);133 112
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 112
Relationship between spatial ability, visuospatial working memory and self-assessed spatial orientation ability: a study in older adults. 112
High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies 112
Normalità e patologia delle funzioni cognitive nell’invecchiamento. 111
ALEXIA WITHOUT AGRAPHIA OR HEMIANOPIA 111
Cognitive demand and reminders effect on prospective memory in MCI patients 110
Il cervello non si “riposa” 110
Lack of seasonal variation in abnormal TSH secretion in patients with seasonal affective disorder 108
Reduction in the arginine vasopressin responses to metoclopramide and insulin-induced hypoglicemia in normal weight bulimic women. 108
Oxytocin enhances thyrotropin-releasing-hormone-induced prolactin release in normal mestruting women 107
Oxytocin enhances thyrotropin-releasing hormone-induced prolactin release in normal menstruating women. 107
L'audizione dicotica in epilettici temporali con o senza lesioni accertabili. 107
Transient Global Amnesia and migraine. 107
Effect of substance P on basal and TRH-stimulated TSH release in humans 106
Cervical pain and odynophagia as unusual presentation of reumathoid arthritis 105
Stereotypic behaviors in degenerative dementias. 104
Decreased drug-cue induced attentional bias in individuals with treated and untread drug dependence 104
Differenze emisferiche nei tempi di reazione semplici in pazienti depressi unipolari non-psicotici. 103
Tower of London Test: a comparison between conventional statistic approach and modelling based on artificial neural network in differentiating fronto-temporal dementia from Alzheimer’s disease 103
Visuospatial planning and problem solving in Alzheimer's disease patients: a study with the Tower of London Test 102
Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in Parkinson's disease. 102
The MMSE pentagon copying is more impaired in Lewy Body dementia than Alzheimer’s Disease. 101
Recovery from transient global amnesia following restoration of hippocampal and fronto cingulate perfusion 101
Evaluation of regional cerebral blood flow using 99mTc-HM-PAO and Single Photon Emission Tomography (SPECT) 101
Discriminant function analysis of Fuld's formula and WAIS subtests in different types of dementia 101
Osservazioni sulla percezione cutanea degli stimoli tattili figurati nell'uomo in condizioni normali. 100
Opioid control of pituitary function in parkinsonian patients before and after dopaminergic therapy 100
Lack of ACTH/cortisol and GH responses to intravenously-infused Substance P in Parkin¬son's disease. 99
Perseverative dysgraphia: a selective disorder in writing double letters 99
Neural basis of endogenous and exogenous spatial orienting: a functional MRI study. 98
Reduced ACTH/cortisol responses to naloxone in men with Parkinson's disease. 98
Fuld's formula and WAIS subtests in differential diagnosis of dementia 97
Orienting of visual attention in Alzheimer’s disease. Its implication in favor of the interhemispheric balance. 96
Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects 96
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease 96
Neuropsychological testing during a transient global amnesia episode and its follow-up. 96
Neuropsychological and neuroimaging correlates of visuospatial impairment in Mild Cognitive Impairment 95
Project Cronos: multiple version of the Mini Mental State Examination ? 95
Italian group for Lewy Body dementia (LBD): presentation of first data collected. 94
Permanent amnesia due to bilateral hipppocampal lesion: report of a clinical case. 94
Low-Dose Ovine Corticotropin-Releasing Hormone Stimulation Test in Diabetes Mellitus With or Without Neuropathy. 94
Totale 22.260
Categoria #
all - tutte 67.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.792


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 0 0 52
2021/20221.124 50 42 37 65 63 48 123 156 103 99 66 272
2022/20233.256 309 280 198 233 260 355 69 237 887 106 207 115
2023/20242.540 165 172 126 208 177 288 230 222 214 237 263 238
2024/20255.702 213 309 500 444 605 663 346 340 642 509 376 755
2025/20268.410 743 725 843 686 1.088 544 941 403 1.137 547 456 297
Totale 26.716